Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02913664 · ClinicalTrials.gov registry record · Phase 2
Risk Reduction for Alzheimer's Disease
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 513
- Enrollment target
NCT02913664 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 513 participants.
The verdict
NCT02913664, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 513 participants
- Enrollment target
Study Summary
Physical inactivity, high blood pressure and dyslipidemia are risk factors for Alzheimer's disease (AD) and vascular dementia. Importantly, these risk factors are modifiable with lifestyle changes, pharmacological treatment, or both. The rrAD study will determine effects of aerobic exercise training and intensive vascular risk reduction on cognitive performance in older adults who have high risk for AD.
Interventions
- OTHER Usual Care
- BEHAVIORAL Aerobic Exercise Training
- DRUG Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
- BEHAVIORAL Stretching Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2017-02-02 |
| Est. Completion | 2022-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02913664
The ClinicalTrials.gov registry entry for NCT02913664 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 513 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT02913664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02913664 about?
NCT02913664 is a clinical study titled "Risk Reduction for Alzheimer's Disease". Physical inactivity, high blood pressure and dyslipidemia are risk factors for Alzheimer's disease (AD) and vascular dementia. Importantly, these risk factors are modifiable with lifestyle changes, pharmacological treatment, or both. The rrAD study will determine effects of aerobic exercise training...
What is the current status of trial NCT02913664?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 513 participants. The study started on 2017-02-02. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT02913664?
The interventions under investigation include: Usual Care (OTHER), Aerobic Exercise Training (BEHAVIORAL), Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine) (DRUG), Stretching Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02913664?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.